Amarin Corp Plc (AMRN)

[alm2]

Retired....
unless the company is bought the crucial price mover over time is sales/profit of V ... if this is a GIA company there will always be a hold back until we see delivery and growth as to sales and profit

But .......Someone else might buy that opportunity on the basis they believe they can grow sales and profit substantially above those being attained by Amarin
The big events - label from FDA and patent loss have come and gone - nothing much else lies ahead which will move the needle - unless usage of V opens into new areas
The fight in USA is to keep and grow sales and profit despite patent loss ... sales /profit will develop in Europe and Row over time

It’s a tough call for a small company which has been repeatedly knocked backwards to keep momentum - whether management could have done better historically is now moot .... whether we like JT and the team or not the reality is they are running the show and nothing but a BO will change that

Too many shares being issued to management .... but they run the show ...

So it’s a slow step by step increase in sales and profit that will drive it back up - 3 to 5 years of GIA being well run world wide and growing profits may see 15 - 20 dollars -
On a turnover / profit / company strength / weakness analysis - that’s how the market will value Amarin

15 - 20 in a buyout in 1 to 2 years is the quickest route we can hope for .... big pharma has all the resources to make things happen quicker bigger and cheaper than Amarin can ever muster

The likelihood of a BO however increases significantly if V can be expanded into multiple usage.... BP has resisted thus far ....... but will the opening of new possibilities as to sales of V become irresistible ???- the next several months will see whether this drug operates significantly in other arenas

We need patience .... and a good headwind behind us
Alm